CIDRAP newsletters options
Longer transmission seasons and migration of mosquitoes to new latitudes threaten to undo years of progress.
The company expects an FDA decision in the first quarter of 2024.
The effect was smaller among females, Asian, Black, and Hispanic race, and patients with lower incomes.
Sales of veterinary and agricultural antibiotics in New Zealand have fallen by 42% since 2017.
The illness, California's first, prompted stepped-up surveillance and efforts to raise awareness.
The findings held true regardless of vaccination status.
WHO officials say they want countries to address the challenges people face when they access healthcare to prevent, diagnose, and treat drug-resistant infections.
The strain, which is believed to have originated in Morocco, has spread rapidly in French hospitals since 2021.
The latest outbreaks in turkeys occurred in Iowa, Minnesota, and South Dakota.
The official report said the farm houses 70,000 animals.
Many public health preparedness directors had to tap into state or national antiviral stockpiles.
The real-world findings underscore the need to manage drug interactions in patients treated with Paxlovid.
The frequency of resistant isolates remains relatively low compared to the number of patients treated with the drug.
Test positivity is still very low, and most subtyped samples are the H1N1 influenza A virus.
Deaths were up a bit, but hospitalizations, emergency department visits, and test positivity trended downward.
Europe had the biggest mpox rise in September, though the Western Pacific region continues to report the highest levels.
Until the Omicron wave in late 2021 and early 2022, Hong Kong had one of the lowest COVID-19 prevalence rates across the globe.
A time-series analysis suggested that patients who acquired COVID-19 in the hospital were the main source of viral spread to other patients.
In patients undergoing knee, hip, and shoulder replacement, administering prophylactic vancomycin in addition to cefazolin did not reduce surgical site infections.
The injectable monoclonal antibody is one of two new prevention strategies to cut the RSV burden in newborns.
